Cargando…
Targeting IgG in Arthritis: Disease Pathways and Therapeutic Avenues
Rheumatoid arthritis (RA) is a polygenic and multifactorial syndrome. Many complex immunological and genetic interactions are involved in the final outcome of the clinical disease. Autoantibodies (rheumatoid factors, anti-citrullinated peptide/protein antibodies) are present in RA patients’ sera for...
Autor principal: | Nandakumar, Kutty Selva |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5877538/ https://www.ncbi.nlm.nih.gov/pubmed/29495570 http://dx.doi.org/10.3390/ijms19030677 |
Ejemplares similares
-
Antibody-induced arthritis: disease mechanisms and genes involved at the effector phase of arthritis
por: Nandakumar, Kutty Selva, et al.
Publicado: (2006) -
Molecular and Cellular Pathways Contributing to Joint Damage in Rheumatoid Arthritis
por: Fang, Qinghua, et al.
Publicado: (2020) -
Possible Future Avenues for Rheumatoid Arthritis Therapeutics: Hippo Pathway
por: Wang, Tao, et al.
Publicado: (2023) -
Impact of Glycosylation on Effector Functions of Therapeutic IgG †
por: Abès, Riad, et al.
Publicado: (2010) -
Autoantibodies as Diagnostic Markers and Mediator of Joint Inflammation in Arthritis
por: Fang, Qinghua, et al.
Publicado: (2019)